Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Ophthalmology
|
July 4, 2013
Fibrin glue for closure of conjunctival incision in strabismus surgery: a report by the american academy of ophthalmology
Michael B Yang, Michele Melia, Scott R Lambert, et al.
Ophthalmology
|
February 12, 2013
Rebound tonometry in children: a report by the American Academy of Ophthalmology
Scott R Lambert, Michele Melia, Angela N Buffenn, et al.
Ophthalmology
|
May 1, 2012
Detection of clinically significant retinopathy of prematurity using wide-angle digital retinal photography: a report by the American Academy of Ophthalmology
Michael F Chiang, Michele Melia, Angela N Buffenn, et al.
Pediatric Neurology
|
March 8, 2021
Pediatric Autoimmune Ocular Myasthenia Gravis: Evaluation of Presentation and Treatment Outcomes in a Large Cohort
Kristen S Fisher, Jason Gill, Hannah F Todd, et al.
Nature
|
January 22, 2013
A direct and melanopsin-dependent fetal light response regulates mouse eye development
Sujata Rao, Christina Chun, Jieqing Fan, et al.
JAMA Ophthalmology
|
November 15, 2019
Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria
Gil Binenbaum, Lauren A Tomlinson, Alejandra G de Alba Campomanes, et al.
Ophthalmology
|
June 6, 2022
Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes
Sharon F Freedman, Amra Hercinovic, David K Wallace, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
|
January 21, 2023
Ocular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurity
David K Wallace, Amra Hercinovic, Sharon F Freedman, et al.
JAMA Ophthalmology
|
April 24, 2020
Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity
David K Wallace, Raymond T Kraker, Sharon F Freedman, et al.
JAMA Ophthalmology
|
April 28, 2017
Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study
David K Wallace, Raymond T Kraker, Sharon F Freedman, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Ophthalmology
|
July 4, 2013
Fibrin glue for closure of conjunctival incision in strabismus surgery: a report by the american academy of ophthalmology
Michael B Yang, Michele Melia, Scott R Lambert, et al.
Ophthalmology
|
February 12, 2013
Rebound tonometry in children: a report by the American Academy of Ophthalmology
Scott R Lambert, Michele Melia, Angela N Buffenn, et al.
Ophthalmology
|
May 1, 2012
Detection of clinically significant retinopathy of prematurity using wide-angle digital retinal photography: a report by the American Academy of Ophthalmology
Michael F Chiang, Michele Melia, Angela N Buffenn, et al.
Pediatric Neurology
|
March 8, 2021
Pediatric Autoimmune Ocular Myasthenia Gravis: Evaluation of Presentation and Treatment Outcomes in a Large Cohort
Kristen S Fisher, Jason Gill, Hannah F Todd, et al.
Nature
|
January 22, 2013
A direct and melanopsin-dependent fetal light response regulates mouse eye development
Sujata Rao, Christina Chun, Jieqing Fan, et al.
JAMA Ophthalmology
|
November 15, 2019
Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria
Gil Binenbaum, Lauren A Tomlinson, Alejandra G de Alba Campomanes, et al.
Ophthalmology
|
June 6, 2022
Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes
Sharon F Freedman, Amra Hercinovic, David K Wallace, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
|
January 21, 2023
Ocular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurity
David K Wallace, Amra Hercinovic, Sharon F Freedman, et al.
JAMA Ophthalmology
|
April 24, 2020
Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity
David K Wallace, Raymond T Kraker, Sharon F Freedman, et al.
JAMA Ophthalmology
|
April 28, 2017
Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study
David K Wallace, Raymond T Kraker, Sharon F Freedman, et al.
Page
of 4